ArticleCureus2024

Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital.

Akash Agnihotri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.